DOCSLIB.ORG

Fis-His-2020-Abstract-Supplement-Free-Paper.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Fis-His-2020-Abstract-Supplement-Free-Paper.Pdf Abstract supplement (free paper abstracts) FIS/HIS International 2020 cannot be held responsible for errors or inconsistencies contained within the abstract supplement. Only major formatting alterations have been made and abstract content remains consistent with what was entered at time of submission by the author/s. How to search this document Laptop, PC or similar: ‘Ctrl’ + ‘F’ or ‘Edit’ then ‘Find’ Smart device: Open this PDF in either the 'iBooks' app (Apple) or 'My Files' app (Android). Both are built in apps and have a magnifying glass search icon. Contents A quick reference guide by topic, paper number and presentation type can be found at the end of the document or click here. (Click paper title to take you straight there) Free paper oral presentations 11: Investigations, actions and learning from an outbreak of SARS-CoV-2 infection among health care workers in the United Kingdom ........................................................................................................................ 13 12: Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care ...................... 14 20: Impact of antibiotic timing on mortality from Gram negative Bacteraemia in an English District General Hospital: the importance of getting it right every time .................................................................................... 15 35: Case report: A fall in the forest ................................................................................................................... 16 65: Not such a fun-guy: A case series of severe urological infections secondary to Nakaseomyces glabrata infection at Nottingham University Hospitals between 2017 and 2019. .......................................................... 17 95: Cryptococcus gattii cryptococcosis microbiological diagnosis in an immunosuppressed traveller to a non- tropical endemic region .................................................................................................................................... 18 97: Hypervirulent Klebsiella pneumoniae: An emerging nosocomial threat .................................................... 19 112: COVID-19 related encephalitis is not an unusual presentation ................................................................ 20 120: Antimicrobial resistance pattern of Community-acquired Urinary Tract Infection from different geographical regions of India ............................................................................................................................ 21 124: Persistence of Pseudomonas aeruginosa (PA) in hospital shower waters and drains and presence of antimicrobial resistance in the augmented-care setting .................................................................................. 22 136: Extended-spectrum β-lactamase-producing Enterobacterales acquisition and incidence of bloodstream infections after relocating to a new hospital with 100% single-occupancy rooms: the MOVE study .............. 23 149: Using metagenomics to study the impact of hospital stay on the human gut resistome ........................ 24 Page 1 of 249 Abstract supplement (free paper abstracts) 157: Serratia marcescens outbreak in a neonatal intensive care unit and the potential of whole-genome sequencing ........................................................................................................................................................ 25 160: Disseminated Ureaplasma urealyticum infection in an immunocompromised patient ........................... 26 163: A review of symptomatology, clinical progression and transmission dynamics in confirmed COVID-19 patients and potential contribution of demographic characteristics on disease susceptibility – preliminary analysis. ............................................................................................................................................................. 27 164: Fight against COVID-19 in Africa: positive lessons for future pandemics from Ghana ............................. 28 168: Is Mycobacterium tuberculosis infection life-long? .................................................................................. 29 181:Clostridioides difficile Spore Survival Upon Recommended Exposure to Sodium Hypochlorite Disi nfectant ............................................................................................................................................................. 30 205: Real-time Monitoring of Aerosol Generating Dental Procedures ............................................................. 31 210: CMV colitis in a young immunocompetent patient .................................................................................. 32 212: A case of Plasmodium falciparum 13 years after leaving an endemic area .............................................. 33 230: Hospital-wide SARS-CoV-2 antibody screening in 4153 staff in a UK hospital - patterns of antibody detection ........................................................................................................................................................... 34 231: Genomic and epidemiological investigations help to clarify the extent of healthcare-associated infection during a hospital outbreak of COVID-19 ............................................................................................ 35 Free paper poster presentations 1: A Prospective Audit of Antimicrobial Stewardship and ‘Start Smart – then Focus’ Compliance on A Vascular Ward. .................................................................................................................................................. 37 2: Comparison of PCR-detected bacterial gastroenteritis cases with their clinical phenotypes: are we over- estimating incidence in hospitalised patients? ................................................................................................. 38 4: Quality Improvement Project. Are we inoculating enough blood volume in paediatric blood culture bottle? ............................................................................................................................................................... 39 7: Selective use of Cepheid Xpert MTB/RIF based on NICE guidelines maintains a high rate of rapid pulmonary TB diagnosis .................................................................................................................................... 41 9: The quality of life and cost benefits of domiciliary 24-hour piperacillin/tazobactam 13.5g infusion in patients with necrotising otitis externa. ........................................................................................................... 42 10: Urogenital schistosomiasis in fishermen in the Mangochi district of Malawi: short-term dynamics of Schistosoma haematobium infections and morbidity after praziquantel treatment ....................................... 43 13: Addressing Refugee Health During the COVID-19 Pandemic and Future Ones .......................................... 44 Page 2 of 249 FIS/HIS International 2020 cannot be held responsible for errors or inconsistencies contained within the abstract supplement. Only major formatting alterations have been made and abstract content remains consistent with what was entered at time of submission by the author/s. Abstract supplement (free paper abstracts) 14: To report a rare case of fungal necrotising otitis externa (NOE) centred on the left temporomandibular joint (TMJ). ........................................................................................................................................................ 45 17: Prevalence of the kleboxymycin biosynthetic gene cluster in Klebsiella spp. ............................................ 46 18: How good is the hand hygiene of surgeons? A data-driven strategy for long-term behavioral change .... 47 19: Resistance and virulence traits of Staphylococcus strains isolated from maternity unit ........................... 48 21: Implementation of Central venous catheter maintenance bundle in an intensive care unit in Kuwait: .... 49 Effect on central line-associated bloodstream infections ................................................................................. 49 23: Tuberculosis with a genitourinary component ........................................................................................... 50 24: Enhancing clinical impact by rapid bacterial identification from blood cultures: the York Teaching Hospital UK experience ..................................................................................................................................... 51 25: A retrospective study of vancomycin prescribing and therapeutic drug monitoring in adult patients with a high creatinine clearance at a large teaching hospital in the East of England, UK: Implications for clinical practice .............................................................................................................................................................. 52 26: Deep learning model for prediction of extended-spectrum beta-lactamase (ESBL) production in community-onset Enterobacterales bacteraemia from a high ESBL prevalence multi-centre cohort ............. 53 27: Retrospective descriptive study of patients with Strongyloides positive serological diagnostic markers referred to a regional infectious diseases unit ................................................................................................. 54 28: Using Quality Improvement
Load more

Recommended publications
  • Comparative Genome Analysis of 19 Ureaplasma Urealyticum and Ureaplasma Parvum Strains
    Paralanov et al. BMC Microbiology 2012, 12:88 http://www.biomedcentral.com/1471-2180/12/88 RESEARCH ARTICLE Open Access Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strains Vanya Paralanov1, Jin Lu2, Lynn B Duffy2, Donna M Crabb2, Susmita Shrivastava1, Barbara A Methé1, Jason Inman1, Shibu Yooseph1, Li Xiao2, Gail H Cassell2, Ken B Waites2 and John I Glass1* Abstract Background: Ureaplasma urealyticum (UUR) and Ureaplasma parvum (UPA) are sexually transmitted bacteria among humans implicated in a variety of disease states including but not limited to: nongonococcal urethritis, infertility, adverse pregnancy outcomes, chorioamnionitis, and bronchopulmonary dysplasia in neonates. There are 10 distinct serotypes of UUR and 4 of UPA. Efforts to determine whether difference in pathogenic potential exists at the ureaplasma serovar level have been hampered by limitations of antibody-based typing methods, multiple cross-reactions and poor discriminating capacity in clinical samples containing two or more serovars. Results: We determined the genome sequences of the American Type Culture Collection (ATCC) type strains of all UUR and UPA serovars as well as four clinical isolates of UUR for which we were not able to determine serovar designation. UPA serovars had 0.75−0.78 Mbp genomes and UUR serovars were 0.84−0.95 Mbp. The original classification of ureaplasma isolates into distinct serovars was largely based on differences in the major ureaplasma surface antigen called the multiple banded antigen (MBA) and reactions of human and animal sera to the organisms. Whole genome analysis of the 14 serovars and the 4 clinical isolates showed the mba gene was part of a large superfamily, which is a phase variable gene system, and that some serovars have identical sets of mba genes.
    [Show full text]
  • Roles of Oral Bacteria in Cardiovascular Diseases—From
    J Pharmacol Sci 113, 000 – 000 (2010) Journal of Pharmacological Sciences ©2010 The Japanese Pharmacological Society Forum Minireview Roles of Oral Bacteria in Cardiovascular Diseases — From Molecular Mechanisms to Clinical Cases: Implication of Periodontal Diseases in Development of Systemic Diseases Hiroaki Inaba1 and Atsuo Amano1,* 1Department of Oral Frontier Biology, Graduate School of Dentistry, Osaka University, Suita 565-0871, Japan Received November 16, 2009; Accepted December 21, 2009 Abstract. Periodontal diseases, some of the most common infectious diseases seen in humans, are characterized by gingival inflammation, as well as loss of connective tissue and bone from around the roots of the teeth, which leads to eventual tooth exfoliation. In the past decade, the as- sociation of periodontal diseases with the development of systemic diseases has received increas- ing attention. Although a number of studies have presented evidence of close relationships between periodontal and systemic diseases, the majority of findings are limited to epidemiological studies, while the etiological details remain unclear. Nevertheless, a variety of recent hypothesis driven investigations have compiled various results showing that periodontal infection and subsequent direct oral-hematogenous spread of bacteria are implicated inPROOF the development of various systemic diseases. Herein, we present current understanding in regard to the relationship between periodon- tal and systemic diseases, including cardiovascular diseases, preterm delivery of low birth weight, diabetes mellitus, respiratory diseases, and osteoporosis. Keywords: periodontal disease, diabetes mellitus, cardiovascular disease, preterm delivery, Porphyromonas gingivalis, oral bacteria 1. Introduction detected in heart valve lesions and atheromatous plaque (5, 6), amniotic fluid of pregnant women with threatened Epidemiological and interventional studies of humans premature labor (11), and placentas from cases of preterm have revealed close associations between periodontal delivery (12, 13).
    [Show full text]
  • Abstract: Introduction: Investigation Into The
    C-109 ASM 106th General Convention - Orlando, Florida - May 22-24, 2006 INVESTIGATION INTO THE EFFECT OF TEMPERATURE ON THE ViaBILITY OF FaSTIDIOUS AND NON-FaSTIDIOUS BaCTERia IN TWO COMMERCiaL AMIES GEL TRANSPORT SYSTEMS: BD CULTURESWAB MaX V(+) AND REMEL BaCTiSWAB. C. BIGGS, THE CHESTER COUNTY HOSPITAL THE CHESTER COUNTY HOSPITAL West Chester, Pennsylvania ABSTRACT: At The Chester County Hospital we use basic insulated cooler boxes with Downingtown, Exton, Kennett Square, and Lionville, Pennsylvania that ice packs for transport of bacteriology swabs from outreach clinics and include various out-patient labs and drawing stations that collect throat physicians offices. During July 2005 we monitored the internal tempera- cultures and urine samples. In addition to this we collect samples from ture of these coolers using digital temperature recorders. Average daily various physicians’ offices. The microbiology lab utilizes a contract cou- temperatures ranged between 11.4 - 19.8º C with peaks as high as 24.3º rier service that is shared with other hospital departments which manages C. We decided to evaluate viability of fastidious bacteria in two Amies Gel the collection of patient samples throughout the day within the network. swab transports; Becton Dickinson CultureSwab Max V(+) (BD) and Transit times for microbiology specimens can vary from 15 minutes Remel BactiSwab (RE) held at room temperature (RT) 20 – 25º C and to several hours depending on timing and courier routing. Before the refrigerator temperature (RF) 4 – 8º C to understand if upgrading our summer of 2005 we had followed guidelines that appear in microbiology coolers to units with electrical refrigeration might improve recovery of reference manuals which advocate the shipment of microbiology swab organisms from swabs.
    [Show full text]
  • Comparison of the Versatrek® and the Bact/ALERT® Blood Culture Systems for the Growth of Fastidious Microorganisms
    VersaTREK Fastidious Organism Recovery 1 American Society of Microbiology Orlando, Florida - 2005 Poster C-214 Comparison of the VersaTREK® and the BacT/ALERT® Blood Culture Systems for the Growth of Fastidious Microorganisms Fastidious organism recovery in automated blood culture systems is poorly documented. For this reason, in-vitro simulations were performed at Duke University Medical Center comparing the VersaTREK Automated Microbial Detection System (VT) (TREK Diagnostic Systems, Cleveland, OH) to the BacT/ALERT system (3D) (bioMeriéux, Inc., Durham, NC). Thirty seven strains of organisms grown from frozen stocks were used in the study. Organisms were diluted in sterile saline and were targeted to achieve a concentration of 10- 100 CFU/ml. REDOX 1® and REDOX 2® bottles from TREK Diagnostic Systems and BacT/ALERT standard aerobic and anaerobic bottles from bioMeriéux were inoculated with the organisms. The bottles were supplemented with fresh human blood prior to incubation in their respective instrument. To further assess media performance, identical bottles were inoculated with the same organism set and were not supplemented with blood. Parameters assessed in the analysis included recovery of the organisms and mean time to detection in hours for both systems in bottles with and without blood. Results demonstrated the VT REDOX 1 bottle was the most productive bottle in the study. The REDOX 1 bottle (with blood) yielded faster time to detection compared to bioMeriéux standard aerobic bottles for 100% of all aerobic organisms tested. Overall detection for VT was 100% (37/37) compared to 97.0% (36/37) for the 3D system with blood supplementation. The VT system had an overall recovery rate of 94.6% (35/37) compared to 86.5% (32/37) for the 3D system without blood supplementation.
    [Show full text]
  • Detection of Neonatal Bacteremia Using 16S Rrna Gene Amplification by Polymerase Chain Reaction
    Egyptian Journal of Medical Microbiology, January 2009 Vol. 18, No. 1 Detection of Neonatal Bacteremia Using 16S rRNA Gene Amplification by Polymerase Chain Reaction Sahar M. Fayed, Azza Abo Senna and Hesham Kamel* Department of Pediatric٭ Department of Clinical Pathology, Banha Faculty of Medicine and Emergencies and Critical Care Children Hospital – Cairo University. ABSTRACT The purpose of this study was to evaluate the potential of a broad diagnostic approach based on 16S rRNA gene amplification and sequencing for rapid detection of neonatal bacteremia. Subjects and Methods: Blood samples were collected from fifty neonates admitted to the neonatal intensive care units with suspected sepsis, for paired analysis of bacterial growth using the BACTEC 9050 instrument and for bacterial 16S rRNA gene using a PCR assay with subsequent DNA sequencing for bacterial species identification. Results: The specimens were positive for bacteria in 43 cases (86%) by blood culture and 44 cases (88%) by PCR out of a total of 50 specimens analysed. There was very good agreement between the results of PCR and blood culture for detection of neonatal bacteremia (kappa ═ 0.8). Taking blood culture as a reference method, the sensitivity, specificity, positive and negative predictive values for PCR were 100%, 75%, 95.5% and 100% respectively after exclusion of candida isolate which was detected by blood culture only and not by PCR( the primer being used was 16S r RNA not 18S r RNA needed to identify fungal sepsis). Concerning the time consumed to detect sepsis, blood culture method took more time (up to 5 days) while PCR took less time <4 hour.
    [Show full text]
  • Culture Medium Supplement for Fastidious Organisms
    Europaisches Patentamt J European Patent Office © Publication number: 0 489 392 A2 Office europeen des brevets © EUROPEAN PATENT APPLICATION © Application number: 91120711.6 © Int. CI.5: C12Q 1/04, C12N 1/38, //(C12N1/38,C12R1:21,1:36) @ Date of filing: 03.12.91 ® Priority: 06.12.90 US 622874 © Applicant: Becton Dickinson and Company One Becton Drive @ Date of publication of application: Franklin Lakes New Jersey 0741 7-1 880(US) 10.06.92 Bulletin 92/24 @ Inventor: Goldenbaum, Paul E. © Designated Contracting States: 732 Silver Creek Road AT BE CH DE DK ES FR GB GR IT LI LU NL SE Baltimore MD 21208(US) Inventor: Graziosi, Ann M. 3619 Gibbons Avenue Baltimore, MD 21208(US) © Representative: von Kreisler, Alek, Dipl.-Chem. et al Patentanwalte Von Kreisler-Selting-Werner, Deichmannhaus am Hauptbahnhof W-5000 Koln 1(DE) © Culture medium supplement for fastidious organisms. © The present invention is a fastidious organism supplement which comprises growth factors and components to neutralize the toxicity of a polyanionic anticoagulant. The supplement is useful to isolate, grow, recover and/or enhance detection of fastidious organisms in culture media. CM < CM Oi CO at CO Rank Xerox (UK) Business Services EP 0 489 392 A2 1 . Field of the Invention This invention relates to a fastidious organism supplement, and more particularly to a neutralizing supplement, and to the use of the supplement in culture media. 5 2. Description of Related Art A polyanionic anticoagulant is an essential ingredient in all blood culture media. Sodium polyanetholesulfonate (SPS) and sodium amylosulfate (SAS) are examples of polyanionic anticoagulants io that may be added to blood culture media.
    [Show full text]
  • CASEE-2017 Session1b -Eva-Tvrda
    A The 8th International CASEE Conference Warsaw University of Life Sciences – SGGW May 14 - 16, 2017 . Decreased sperm quality visible in routine semen analysis: . loss of sperm motility . morphological alterations . acrosome dysfunction . disruption of membrane integrity . oxidative stress . Most data connected to bacterial contamination of ejaculates: well-known causative agents of urogenital tract infections . Escherichia coli, Staphylococcus aureus, Ureaplasma urealyticum, Mycoplasma hominis, Chlamydia trachomatis . Ejaculates collected for reproductive technologies - certain contamination: . semen collection is not an entirely serile process . factors for semen contamination: artifical vaginas, environmental conditions, human factors . Current interest shifts to other bacteria, responsible for the colonization and contamination of the male urogenital tract, rather than infection . Gram-positive, catalase-negative, non-spore-forming, facultative anaerobic bacteria . Lactic acid bacteria (LAB) that produce bacteriocins . Origins: environmental, animal and human sources . E. faecalis: . most common in the gastrointestinal tract, and may be found in human and animal faeces . associated with clinical urinary tract infections, hepatobiliary sepsis, endocarditis, surgical wound infection, bacteraemia and neonatal sepsis . able to survive a range of adverse environments allowing multiple routes of cross- contamination . resistant to a broad range of antibiotics including ampicillin, ciprofloxacin and imipenem ANTIBIOTICS NATURALLY OCCURING
    [Show full text]
  • GBS 10 Strep11 Other 60 Vaginal Swabs! Real-Time LAMP!
    • Specificity studies were performed using a panel of 10 Group B Streptococcus agalactiae strains, 11 of the most commonly occurring Streptococcus genus strains and 60 other organisms commonly found in the human genital tract. • One hundred and twenty four (124) vaginal swabs sampled from pregnant women were tested with the real-time LAMP assay and compared to a real- time PCR assay (5). Neonatal infections are most commonly caused by Group B Streptococcus GBS 10 (Streptococcus agalactiae) (1). These infections can be classified as either early on-set • Of the 124 vaginal swabs, 85 tested positive for Group B Streptococcus and & or late-onset disease. Early onset infection (EOI) occurs during the first week of life 39 tested negative. with late onset infection (LOI) occurring between one week and three months. It is Strep11 thought that early onset disease develops in the foetus after aspiration of infected • Comparable results were achieved by both the real-time PCR and real –time amniotic fluid (2). Late onset infection is less well understood, and while passage LAMP assays. Results are listed in Table 4. Also shown in the table are through the birth canal is an obvious route of infection, it is also thought that community previously obtained microbiological culture data for the isolation and sources are involved (2). Other identification of GBS. 60 One approach used to identify potential for infection is a screening of pregnant women, where prophylaxis is offered to those identified as carriers (3). This approach is also • Figure 1: Breakdown of specificity panels investigated during the development of the Table 2: Results of GBS testing of vaginal swabs.
    [Show full text]
  • Research Article Rapid PCR Detection of Mycoplasma Hominis, Ureaplasma Urealyticum,Andureaplasma Parvum
    Hindawi Publishing Corporation International Journal of Bacteriology Volume 2013, Article ID 168742, 7 pages http://dx.doi.org/10.1155/2013/168742 Research Article Rapid PCR Detection of Mycoplasma hominis, Ureaplasma urealyticum,andUreaplasma parvum Scott A. Cunningham,1 Jayawant N. Mandrekar,2 Jon E. Rosenblatt,1 and Robin Patel1,3 1 Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA 2 Division of Biomedical Statistics and Informatics, Department of Health Science Research, Mayo Clinic, Rochester, MN 55905, USA 3 Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA Correspondence should be addressed to Robin Patel; [email protected] Received 5 November 2012; Accepted 30 January 2013 Academic Editor: Sam R. Telford Copyright © 2013 Scott A. Cunningham et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective. We compared laboratory developed real-time PCR assays for detection of Mycoplasma hominis and for detection and differentiation of Ureaplasma urealyticum and parvum to culture using genitourinary specimens submitted for M. hominis and Ureaplasma culture. Methods. 283 genitourinary specimens received in the clinical bacteriology laboratory for M. hominis and Ureaplasma species culture were evaluated. Nucleic acids were extracted using the Total Nucleic Acid Kit on the MagNA Pure 2.0. 5 L of the extracts were combined with 15 L of each of the two master mixes. Assays were performed on the LightCycler 480 II system. Culture was performed using routine methods.
    [Show full text]
  • Prevalence of Ureaplasma Urealyticum, Mycoplasma Hominis and Chlamydia Trachomatis in Patients with Uncomplicated Recurrent Urin
    Nephrology and Renal Diseases Research Article ISSN: 2399-908X Prevalence of Ureaplasma urealyticum, Mycoplasma hominis and Chlamydia trachomatis in patients with uncomplicated recurrent urinary tract infections Jadranka Vlasic-Matas1*, Hrvoje Raos2, Marijana Vuckovic2, Stjepan Radic2 and Vesna Capkun3 1Polyclinic Nephrology Department, Split, Croatia 2School of Medicine, University of Split, Split, Croatia 3Department of Nuclear Medicine, Split University Hospital Center, Split, Croatia Abstract Aim: To assess the prevalence of Ureaplasma urealyticum, Mycoplasma hominis and Chlamydia trachomatis in patients with chronic urinary tract infections (UTIs) and its correlation with leukocyturia and symptoms. Methods: The study included 220 patients (130 women and 90 men) presenting with chronic voiding symptoms and sterile leukocyturia. Urine, urethral swabs and cervical swabs (for women patients) were taken to determine the presence of these pathogens. Patients were treated by tetracycline and followed up three and six months after initial therapy. Results: In 186 (85%) out of 220 patients, U. urealyticum was found, while C. trachomatis was present in 34 patients (15%). In majority of female patients (112 out of 130; 86%) U. urealyticum was found. In addition to ureaplasma, in eight patients M. hominis was found. C. trachomatis was identified in 18 female patients (14%). In 74 out of 90 (82%) male patients U. urealyticum was detected while in six of them M. hominis was also found. C. trachomatis was identified in 16 male patients (18%). U. urealyticum was significantly related to leukocyturia, as opposed to C. trachomatis (p<0,001). Women had more frequent symptomatology (p = 0,015) and higer leukocyturia (p<0.001). Conclusion: Leukocyturia is more common find in U.
    [Show full text]
  • Anterior Nares Acidovorax Ebreus 100% Acidovorax Sp
    Anterior Nares Acidovorax ebreus 100% Acidovorax sp. Acinetobacter johnsonii Acinetobacter lwoffii 10% Actinobacillus minor Actinomyces odontolyticus Actinomyces sp. 1% Actinomyces urogenitalis Aggregatibacter aphrophilus Alistipes putredinis 0.1% Anaerococcus hydrogenalis Anaerococcus lactolyticus 0.01% Anaerococcus prevotii Anaerococcus tetradius Anaerococcus vaginalis 0.001% Atopobium vaginae Bacteroides dorei Bacteroides intestinalis 0.0001% Bacteroides sp. Bacteroides stercoris Bacteroides vulgatus 0.00001% Campylobacter concisus Campylobacter gracilis Campylobacter hominis Campylobacter lari Campylobacter showae Candidate division Capnocytophaga gingivalis Capnocytophaga ochracea Capnocytophaga sputigena Cardiobacterium hominis Catonella morbi Citrobacter sp. Clostridium leptum Corynebacterium accolens Corynebacterium ammoniagenes Corynebacterium amycolatum Corynebacterium diphtheriae Corynebacterium efficiens Corynebacterium genitalium Corynebacterium glutamicum Corynebacterium jeikeium Corynebacterium kroppenstedtii Corynebacterium lipophiloflavum Corynebacterium matruchotii Corynebacterium pseudogenitalium Corynebacterium pseudotuberculosis Corynebacterium resistens Corynebacterium striatum Corynebacterium tuberculostearicum Corynebacterium urealyticum Delftia acidovorans Dialister invisus Eikenella corrodens Enhydrobacter aerosaccus Eubacterium rectale Finegoldia magna Fusobacterium nucleatum Fusobacterium periodonticum Fusobacterium sp. Gardnerella vaginalis Gemella haemolysans Granulicatella adiacens Granulicatella elegans Haemophilus
    [Show full text]
  • Laboratory Diagnosis of Sexually Transmitted Infections, Including Human Immunodeficiency Virus
    Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus human immunodeficiency including Laboratory transmitted infections, diagnosis of sexually Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus Editor-in-Chief Magnus Unemo Editors Ronald Ballard, Catherine Ison, David Lewis, Francis Ndowa, Rosanna Peeling For more information, please contact: Department of Reproductive Health and Research World Health Organization Avenue Appia 20, CH-1211 Geneva 27, Switzerland ISBN 978 92 4 150584 0 Fax: +41 22 791 4171 E-mail: [email protected] www.who.int/reproductivehealth 7892419 505840 WHO_STI-HIV_lab_manual_cover_final_spread_revised.indd 1 02/07/2013 14:45 Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus Editor-in-Chief Magnus Unemo Editors Ronald Ballard Catherine Ison David Lewis Francis Ndowa Rosanna Peeling WHO Library Cataloguing-in-Publication Data Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus / edited by Magnus Unemo … [et al]. 1.Sexually transmitted diseases – diagnosis. 2.HIV infections – diagnosis. 3.Diagnostic techniques and procedures. 4.Laboratories. I.Unemo, Magnus. II.Ballard, Ronald. III.Ison, Catherine. IV.Lewis, David. V.Ndowa, Francis. VI.Peeling, Rosanna. VII.World Health Organization. ISBN 978 92 4 150584 0 (NLM classification: WC 503.1) © World Health Organization 2013 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO web site (www.who.int/about/licensing/copyright_form/en/index.html).
    [Show full text]